1. Home
  2. HOTH vs BREA Comparison

HOTH vs BREA Comparison

Compare HOTH & BREA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HOTH
  • BREA
  • Stock Information
  • Founded
  • HOTH 2017
  • BREA 2022
  • Country
  • HOTH United States
  • BREA Ireland
  • Employees
  • HOTH N/A
  • BREA N/A
  • Industry
  • HOTH Biotechnology: Pharmaceutical Preparations
  • BREA Services-Misc. Amusement & Recreation
  • Sector
  • HOTH Health Care
  • BREA Consumer Discretionary
  • Exchange
  • HOTH Nasdaq
  • BREA Nasdaq
  • Market Cap
  • HOTH 8.3M
  • BREA 9.4M
  • IPO Year
  • HOTH 2019
  • BREA 2023
  • Fundamental
  • Price
  • HOTH $1.30
  • BREA $0.72
  • Analyst Decision
  • HOTH Strong Buy
  • BREA
  • Analyst Count
  • HOTH 3
  • BREA 0
  • Target Price
  • HOTH $4.00
  • BREA N/A
  • AVG Volume (30 Days)
  • HOTH 2.4M
  • BREA 88.4K
  • Earning Date
  • HOTH 05-12-2025
  • BREA 01-03-2025
  • Dividend Yield
  • HOTH N/A
  • BREA N/A
  • EPS Growth
  • HOTH N/A
  • BREA N/A
  • EPS
  • HOTH N/A
  • BREA N/A
  • Revenue
  • HOTH N/A
  • BREA $2,988,009.00
  • Revenue This Year
  • HOTH N/A
  • BREA N/A
  • Revenue Next Year
  • HOTH N/A
  • BREA N/A
  • P/E Ratio
  • HOTH N/A
  • BREA N/A
  • Revenue Growth
  • HOTH N/A
  • BREA 151.51
  • 52 Week Low
  • HOTH $0.58
  • BREA $0.50
  • 52 Week High
  • HOTH $3.80
  • BREA $1.95
  • Technical
  • Relative Strength Index (RSI)
  • HOTH 64.78
  • BREA 57.96
  • Support Level
  • HOTH $0.88
  • BREA $0.66
  • Resistance Level
  • HOTH $1.78
  • BREA $0.72
  • Average True Range (ATR)
  • HOTH 0.16
  • BREA 0.04
  • MACD
  • HOTH 0.05
  • BREA 0.00
  • Stochastic Oscillator
  • HOTH 50.72
  • BREA 67.84

About HOTH Hoth Therapeutics Inc.

Hoth Therapeutics Inc is a development-stage biopharmaceutical company. It is focused on targeted therapeutics for patients suffering from conditions such as atopic dermatitis, also known as eczema, chronic wounds, psoriasis, asthma, and acne. The company owns the BioLexa Platform which combines an FDA-approved zinc chelator with one or more approved antibiotics in a topical dosage form to address unchecked eczema flare-ups.

About BREA Brera Holdings PLC

Brera Holdings PLC focused on expanding social impact football by developing a international portfolio of emerging football clubs with increased opportunities to earn tournament prizes, gain sponsorships, and provide other professional football and related consulting services.

Share on Social Networks: